The DNA-encoded libraries platforms and services market is projected to be reach USD 4 billion
Using DNA to develop encoded libraries of pharmacological leads has enabled medical research community to assemble and maintain large collections of compounds in singular reaction tubes, capturing the attention of small and big pharma players
By: Roots Analysis
Roots Analysis has announced the addition of "DNA-Encoded Libraries: Platforms and Services Market, 2020-2030" report to its list of offerings.
Over time, a variety of methods have been developed and implemented for the synthesis of DNA-encoded molecular libraries. The availability of such cost-effective screening technologies has disrupted the pharmacological lead discovery process. In fact, it has been demonstrated to significantly increase drug discovery throughput, compared to conventional technologies / methods.
To order this report, which features 40+ figures and 45+ tables, please visit this link (https://www.rootsanalysis.com/
Key Market Insights
Close to 30 DNA-encoded libraries are currently available / under development
Of these, over 20 libraries are designed for discovery of small molecule drugs, while others are presently suited for macrocycle leads. Presently, majority of these libraries (27%) contain more than 90 billion molecules and are primarily synthesized through the DNA-conjugate method (using the split-and-pool approach).
More than 50% of the firms offering DNA-encoded libraries are small-sized initiatives
This is followed by mid-sized and very large players, which capture 40% of the overall share; examples include (in alphabetical order, no selection criteria) ComInnex, Edelris, Nurix Therapeutics, Pharmaron and WuXi AppTec.
Europe is currently considered a hub for the synthesis and use of DNA-encoded libraries
We identified around 30 players that claimed to be engaged in the development of DNA-encoded libraries in this region. Prominent countries, where companies working on encoded molecular libraries are based include (in decreasing order of number of players) the US, China, Denmark, Switzerland, and Hungary.
~60% of the revenues generated by DNA encoded library providers are estimated to be from milestone payments
By 2030, the market is expected to witness significant growth as the demand for novel molecules continues to increase. As a result, ongoing efforts and anticipated drug discovery initiatives are likely to translate into opportunities for companies offering DNA-encoded libraries.
To request a sample copy / brochure of this report, please visit this link (https://www.rootsanalysis.com/
+1 (415) 800 3415
+44 (122) 391 1091